- Udyam number
- UDYAM-TS-02-0012966

About Croissance Clinical Research Private Limited
Data last updated:
Croissance Clinical Research Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2013PTC087677. Its GSTIN is 36AAFCC2606L1ZP (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹68.18 Lakh. It is led by directors Satish Yadav Marukurthi (Managing Director) and Bharathi Marukurthi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.07 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.01 Cr (net margin 6.7%) and EBITDA of ₹1.9 Cr (EBITDA margin 12.6%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 51% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Croissance Clinical Research. As per MCA filings, the company has open charges of ₹1.65 Cr on record.
Croissance Clinical Research Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0012966). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website croissancecr.com.
Company details
CIN history
Croissance Clinical Research has one previous CIN (Corporate Identification Number): U74900AP2013PTC087677. The current CIN is U74900TG2013PTC087677, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900TG2013PTC087677 | Current |
| U74900AP2013PTC087677 | Previous |
Recognitions & Rankings of Croissance Clinical Research
Contact details
Croissance Clinical Research Private Limited's registered office is in Hyderabad, Telangana. Its website is croissancecr.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 37 2nd Floor Smarco Rahul Matrusri Nagar Gate No. 5 Near Miyapur X Roads, Miyapur, Hyderabad, Telangana, India – 500049
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Croissance Clinical Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Croissance Clinical Research operates one associated brand: Croissance Clinical Research. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers integrated services for clinical development in healthcare. | croissancecr.com |
Business activity
The main business activity of Croissance Clinical Research is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Croissance Clinical Research Private Limited, buy the company report.
Financials of Croissance Clinical Research Private Limited
FY 2025 filings availableCroissance Clinical Research Private Limited reported revenue of ₹15.07 Cr (up 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 19% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.6% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Croissance Clinical Research Private Limited, buy the company report.
Board of directors of Croissance Clinical Research Private Limited
Croissance Clinical Research has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharathi Marukurthi | Director | 01 Dec 2014 | 11 Years 11 Months | Current |
| Satish Yadav Marukurthi | Managing Director | 16 May 2013 | 13 Years 6 Months | Current |
Auditor
Croissance Clinical Research Private Limited is audited by GALI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GALI & ASSOCIATES | FY 2023 | 016102S |
Shareholding
The shareholding of Croissance Clinical Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Croissance Clinical Research Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jan 2021 | 100443368 | Others | ₹65 Lakh | Open | |
| 10 Jul 2020 | 100352189 | Hdfc Bank Limited | ₹1 Cr | Open |
To see the full charge records of Croissance Clinical Research Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Croissance Clinical Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Croissance Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Croissance Clinical Research Private Limited has a workforce of 10 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 10 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Croissance Clinical Research Private Limited, buy the company report.
GST
Croissance Clinical Research has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCC2606L1ZP | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Croissance Clinical Research Private Limited, buy the company report.
Recent activity
Croissance Clinical Research Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Shanthi Latha Kothamasu ceased to be Additional Director on 10 Dec 2014.
1 earlier event is in the company report.
Frequently asked questions
Croissance Clinical Research is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 May 2013 (13+ years old) and is registered under CIN U74900TG2013PTC087677.
Croissance Clinical Research has 2 current directors:
- Satish Yadav Marukurthi - Managing Director
- Bharathi Marukurthi - Director
The latest financial statements of Croissance Clinical Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Croissance Clinical Research is 36AAFCC2606L1ZP, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Croissance Clinical Research is U74900TG2013PTC087677. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Croissance Clinical Research was incorporated on 16 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Shanthi Latha Kothamasu ceased to be Additional Director on 10 Dec 2014. Bharathi Marukurthi was appointed as Director on 01 Dec 2014. Sridhar Reddy Bhumireddy Peddireddy ceased to be Director on 05 Apr 2014. Croissance Clinical Research has 7 board changes on record in total.
Yes, Croissance Clinical Research is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0012966).
Croissance Clinical Research can be reached through the website croissancecr.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Croissance Clinical Research is at Plot No. 37 2nd Floor Smarco Rahul Matrusri Nagar Gate No. 5 Near Miyapur X Roads, Miyapur, Hyderabad, Telangana, India – 500049.

